Press release content from Business Wire. The AP news staff was not involved in its creation.
Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases Including COVID-19
April 20, 2021 GMT
New Prestige BioPharma vaccine centre in South Korea (Photo: Business Wire)
SINGAPORE (BUSINESS WIRE) Apr 20, 2021
Prestige Biopharma Limited (PBP), specializing in the development of antibody therapeutics, announces that the company will be introducing a vaccine development and production centre into its core business. PBP has been preparing for a business expansion into the development of vaccine-based therapeutics since the start of the ongoing COVID-19 outbreak as a response to the current, and potential future, viral pandemics. The design, development and implementation of the vaccine centre has resulted from that plan.
Prestige Biopharma to open vaccine production centre in South Korea
Prestige Biopharma to open vaccine production centre in South Korea 20 April 2021 | News
Image credit- businesswire
Prestige Biopharma Limited (PBP), based in Singapore, has announced that the company will be introducing a vaccine development and production centre into its core business.
PBP has been preparing for a business expansion into the development of vaccine-based therapeutics since the start of the ongoing COVID-19 outbreak as a response to the current, and potential future, viral pandemics. The design, development and implementation of the vaccine centre has resulted from that plan.
PBP is on target to complete the construction of its global-scale vaccine production facility in Osong, South Korea with a total area of approximately 8,500 m